Downloadable Slideset


Share

Program Content

Activities

  • Key Variables in Treating CLL/SLL
    Individualizing the Care of Patients with CLL/SLL: Key Variables in Treatment-Decision Making
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 02, 2023

  • Relapsed or Refractory CLL
    Effective Management of Patients with Relapsed/Refractory CLL/SLL
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 02, 2023

  • Newly Diagnosed CLL
    Management of Patients with Newly Diagnosed CLL/SLL
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 02, 2023

Faculty

cover img faculity

Jeremy S Abramson, MD, MMSc

Director, Center for Lymphoma
Mass General Cancer Center
Associate Professor of Medicine
Harvard Medical School
Boston, Massachusetts

cover img faculity

Farrukh T Awan, MD, MS, MBA

Professor of Internal Medicine
Director of Lymphoid Malignancies Program
Harold C. Simmons Comprehensive Cancer Center
University of Texas Southwestern Medical Center
Dallas, Texas

cover img faculity

Brian T Hill, MD, PhD

Director, Lymphoid Malignancies Program
Staff Physician, Department of Hematology and Medical Oncology
Taussig Cancer Institute
Cleveland Clinic
Cleveland, Ohio

Provided by

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca, BeiGene Ltd, and Lilly. Supported by independent educational grants from Merck & Co., Inc., Rahway, NJ, USA, and Pharmacyclics, an AbbVie Company and Janssen Biotech, Inc.

AstraZeneca

BeiGene, Ltd.

Janssen Biotech, Inc.

Lilly

Merck Sharp & Dohme Corp.

Pharmacyclics LLC, an AbbVie Company

Partners

Clinical Care Options, LLC

ProCE Banner